# Arcutis Biotherapeutics, Inc.: Form 8-K, filed Mar 4, 2024

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 8-K
- Filed: 2024-03-04
- Accepted by EDGAR: Mar 4, 2024, 16:10 ET
- Period: 2024-02-28
- Accession: 0001628280-24-008496
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/arqt-20240228.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/arqt-20240228.htm

Filed Mar 4, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-008496. Last ingested by Listed: Oct 28, 2026, 09:04 ET. No prices; not investment advice.